Global Biologic and Medical Imaging Reagents Market Growth (Status and Outlook) 2025-2031

The global Biologic and Medical Imaging Reagents market size is predicted to grow from US$ 24700 million in 2025 to US$ 42680 million in 2031; it is expected to grow at a CAGR of 9.5% from 2025 to 2031.

Biological and Medical Imaging Reagents are chemicals that clinicians and healthcare providers can determine whether a tumor is malignant or benign, and can locate any metastatic cancer in the body, specifically designed to enhance the image produced by the imaging system.

The global well-known brands in Biologic and Medical Imaging Reagents include Cardinal Health(6.77%), Bracco(5.41%), Bayer HealthCare(3.48%), Curium Pharma(2.02%), Hengrui Medicine(2.67%), GE Healthcare(2.53%), Lantheus Medical Imaging(2.01%), Novartis (AAA)(2.77%), Thermo Fisher Scientific(2.16%), Jubilant DraxImage(1.63%), PerkinElmer(1.44%), Guerbet(1.75%), Nihon Medi-Physics(1.75%), YRPG(1.09%) and Others(62.52%).

The application area of Biologic and Medical Imaging Reagents include Hospitals, Clinics and Other.

In terms of types, Biologic and Medical Imaging Reagents can be divided into Nuclear Imaging (PET & SPECT) Reagents, Magnetic Resonance Imaging (MRI) Reagents, Fluorescence Imaging Reagents, Ultrasound and X-ray Contrast Reagents and Other.

On basis of geography, Biologic and Medical Imaging Reagents are manufactured in North America, Europe, China and Japan.

LPI (LP Information)' newest research report, the “Biologic and Medical Imaging Reagents Industry Forecast” looks at past sales and reviews total world Biologic and Medical Imaging Reagents sales in 2024, providing a comprehensive analysis by region and market sector of projected Biologic and Medical Imaging Reagents sales for 2025 through 2031. With Biologic and Medical Imaging Reagents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologic and Medical Imaging Reagents industry.

This Insight Report provides a comprehensive analysis of the global Biologic and Medical Imaging Reagents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Biologic and Medical Imaging Reagents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Biologic and Medical Imaging Reagents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologic and Medical Imaging Reagents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologic and Medical Imaging Reagents.

This report presents a comprehensive overview, market shares, and growth opportunities of Biologic and Medical Imaging Reagents market by product type, application, key players and key regions and countries.

Segmentation by Type:
Nuclear Imaging (PET & SPECT) Reagents
Magnetic Resonance Imaging (MRI) Reagents
Fluorescence Imaging Reagents
Ultrasound and X-ray Contrast Reagents
Other

Segmentation by Application:
Hospitals
Clinics
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cardinal Health
Bracco
Bayer HealthCare
Curium Pharma
Hengrui Medicine
GE Healthcare
Lantheus Medical Imaging
Novartis (AAA)
Thermo Fisher Scientific
Jubilant DraxImage
PerkinElmer
Guerbet
Nihon Medi-Physics
YRPG

Please note: The report will take approximately 2 business days to prepare and deliver.